It is noteworthy that, in human hepatocellular carcinoma, GLS2 expression positively correlates with the level of miR-122, which inhibits GLS expression; moreover, Gls2 expression is lower in liver tissues from miR-122 knockout mice compared to wild-type animals [54]. The gene discussed is GLS; the disease is hepatocellular carcinoma.